| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/07/2011 | WO2011039724A1 Antibodies that specifically bind to the epha2 receptor |
| 04/07/2011 | WO2011039721A1 New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody |
| 04/07/2011 | WO2011039510A2 Conjugates targeting the cd163 receptor |
| 04/07/2011 | WO2011039370A1 Bispecific binding molecules for anti-angiogenesis therapy |
| 04/07/2011 | WO2011039368A2 Dll4-binding molecules |
| 04/07/2011 | WO2011039274A1 Multistep final filtration |
| 04/07/2011 | WO2011039126A1 Bispecific death receptor agonistic antibodies |
| 04/07/2011 | WO2011039096A1 Drug fusions and conjugates with extended half life |
| 04/07/2011 | WO2011039012A1 Pre-filtration adjustment of buffer solutes |
| 04/07/2011 | WO2011038894A1 Protein a chromatography |
| 04/07/2011 | WO2011038700A1 Inhibitors of fam3b gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals |
| 04/07/2011 | WO2011038689A1 Novel human cytokine vstm1-v2 and use thereof |
| 04/07/2011 | WO2011038575A1 Novel antibody treatment |
| 04/07/2011 | WO2011012309A8 Muc1 antibodies |
| 04/07/2011 | WO2010091354A3 Akt tyrosine 176 phosphorylation cancer biomarker |
| 04/07/2011 | WO2010091049A3 Diagnosis and treatment of cancer |
| 04/07/2011 | US20110082284 Gene overexpressed in cancer |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082094 Mammalian Cytokine-Like Polypeptide-10 |
| 04/07/2011 | US20110082089 Biomarkers for monitoring or predicting the treatment of cancer |
| 04/07/2011 | US20110081707 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 04/07/2011 | US20110081658 T1r3 binding assays |
| 04/07/2011 | US20110081656 Secreted proteins and uses thereof |
| 04/07/2011 | US20110081642 Selection of B Cells with Specificity of Interest: Method of Preparation and Use |
| 04/07/2011 | US20110081408 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081407 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081406 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/07/2011 | US20110081361 Antibodies that bind interleukin-4 receptor |
| 04/07/2011 | US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 04/07/2011 | US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 04/07/2011 | US20110081357 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 04/07/2011 | US20110081354 Anti-ctla-4 antibodies with reduced blocking of binding of ctla-4 to b7 and uses thereof |
| 04/07/2011 | US20110081353 Antibody against the csf-1 r |
| 04/07/2011 | US20110081352 Immunogenic peptides and methods of use for treating and preventing cancer |
| 04/07/2011 | US20110081351 Antihuman baff antibody |
| 04/07/2011 | US20110081350 Synthetic scFv Analogue To The 6313/G2 (Anti Angiotensin II Type 1 Receptor) Monoclonal Antibody Variable Regions |
| 04/07/2011 | US20110081349 Allergenic latex protein |
| 04/07/2011 | US20110081348 Fungal signalling and metabolic enzymes |
| 04/07/2011 | US20110081347 Antibodies with Altered Binding to FcRn and Methods of Using Same |
| 04/07/2011 | US20110081346 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081343 Vaccines directed to langerhans cells |
| 04/07/2011 | US20110081342 Anti-vegf antibodies |
| 04/07/2011 | US20110081292 Methods Of Treating Viral Hepatitis |
| 04/07/2011 | DE102009045268A1 Neue Marker für die Diagnose von Zöliakie New marker for the diagnosis of celiac disease |
| 04/07/2011 | CA2779506A1 Methods of improving vaccine immunogenicity |
| 04/07/2011 | CA2776534A1 Piscine reovirus diagnostic compositions |
| 04/07/2011 | CA2776386A1 Piscine reovirus immunogenic compositions |
| 04/07/2011 | CA2776271A1 Anti-hsv antibody |
| 04/07/2011 | CA2776144A1 Influenza hemagglutinin antibodies, compositions, and related methods |
| 04/07/2011 | CA2776143A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 04/07/2011 | CA2776037A1 Anti-fibroblast activation protein antibodies and methods and uses thereof |
| 04/07/2011 | CA2776022A1 Antibodies that specifically bind to the epha2 receptor |
| 04/07/2011 | CA2775880A1 Methods of treating cancer using notch antagonists |
| 04/07/2011 | CA2775685A1 Monoclonal antibody against human hig-1 polypeptide |
| 04/07/2011 | CA2775422A1 Bispecific binding molecules for anti-angiogenesis therapy |
| 04/07/2011 | CA2775420A1 Dll4-binding molecules |
| 04/07/2011 | CA2774999A1 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| 04/07/2011 | CA2774916A1 New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody |
| 04/07/2011 | CA2774552A1 Drug fusions and conjugates with extended half life |
| 04/07/2011 | CA2774427A1 Antibodies specifically binding to the epidermal growth factor receptor |
| 04/07/2011 | CA2774256A1 Monoclonal antibodies |
| 04/07/2011 | CA2773674A1 Multistep final filtration |
| 04/07/2011 | CA2773515A1 Bispecific death receptor agonistic antibodies |
| 04/07/2011 | CA2772846A1 Pre-filtration adjustment of buffer solutes |
| 04/06/2011 | EP2306192A2 Risk Markers For Cardiovascular Disease |
| 04/06/2011 | EP2305836A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/06/2011 | EP2305827A1 Cancer antigen MAGE-A9 and uses thereof |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305816A1 Mutation in the Parkin gene, compositions, methods and uses |
| 04/06/2011 | EP2305798A2 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 04/06/2011 | EP2305717A1 Inhibiting TNIK for treating colon cancer |
| 04/06/2011 | EP2305716A2 Antibodies directed to gpnmb and uses thereof |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305711A2 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 04/06/2011 | EP2305710A2 Synthetic antibody phage libraries |
| 04/06/2011 | EP2305709A1 Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods for use thereof |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305306A1 Neuroinvasion inhibitor |
| 04/06/2011 | EP2305303A2 Immunization against Clostridium difficile disease |
| 04/06/2011 | EP2305302A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305301A2 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 04/06/2011 | EP2305300A1 Pharmaceutical composition for treatment and prevention of cancer |
| 04/06/2011 | EP2305296A1 Immunogenic composition for use in vaccination against staphylococcei |
| 04/06/2011 | EP2305295A1 Immunogenic composition for use in vaccination against staphylococcei |
| 04/06/2011 | EP2305294A1 Immunogenic composition for use in vaccination against staphylococcei |
| 04/06/2011 | EP2305293A2 Immunization against Clostridium difficile disease |
| 04/06/2011 | EP2305284A2 Use of EGFR transactivation inhibitors in human cancer |
| 04/06/2011 | EP2305282A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305242A2 20-carboxy-(S)-trioxilin A3 for treating neurologic disorders |
| 04/06/2011 | EP2305027A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 04/06/2011 | EP2304441A2 A method for the screening of conserved secreted proteins |
| 04/06/2011 | EP2304440A1 Novel monoclonal antibodies against hpv proteins |